Results 1 to 10 of about 8,797 (182)

Correcting for sparsity and interdependence in glycomics by accounting for glycan biosynthesis

open access: yesNature Communications, 2021
Glycomics can uncover important molecular changes but measured glycans are highly interconnected and incompatible with common statistical methods, introducing pitfalls during analysis. Here, the authors develop an approach to identify glycan dependencies
Austin W T Chiang   +2 more
exaly   +2 more sources

Towards a standardized bioinformatics infrastructure for N- and O-glycomics

open access: yesNature Communications, 2019
Glycomics is gaining momentum in basic, translational and clinical research. Here, the authors review current reporting standards and analysis tools for mass-spectrometry-based glycomics, and propose an e-infrastructure for standardized reporting and ...
Vignesh Venkatakrishnan   +2 more
exaly   +2 more sources

Systematic Evaluation of Normalization Methods for Glycomics Data Based on Performance of Network Inference

open access: yesMetabolites, 2020
Glycomics measurements, like all other high-throughput technologies, are subject to technical variation due to fluctuations in the experimental conditions. The removal of this non-biological signal from the data is referred to as normalization.
Igor Rudan   +2 more
exaly   +3 more sources

Compositional data analysis enables statistical rigor in comparative glycomics

open access: yesNature Communications
Comparative glycomics data are compositional data, where measured glycans are parts of a whole, indicated by relative abundances. Applying traditional statistical analyses to these data often results in misleading conclusions, such as spurious “decreases”
Morten Andersen   +2 more
exaly   +2 more sources

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils

open access: yesNature Communications, 2023
Mucosally active subunit vaccines are an unmet clinical need due to lack of licensed immunostimulants suitable for vaccine antigens. Here, we show that intranasal administration of liposomes incorporating: the Streptococcus pyogenes peptide antigen, J8 ...
Victoria Ozberk   +13 more
doaj   +1 more source

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines

open access: yesScientific Reports, 2021
We have developed two candidate vaccines to protect against multiple strains of Strep A infections. The candidates are combinatorial synthetic peptide vaccines composed of a M protein epitope (J8 or p*17) and a non-M protein epitope (K4S2).
Simone Reynolds   +7 more
doaj   +1 more source

Discovery of Cofactor Competitive Inhibitors against the Human Methyltransferase Fibrillarin

open access: yesPharmaceuticals, 2021
Fibrillarin (FBL) is an essential and evolutionarily highly conserved S-adenosyl methionine (SAM) dependent methyltransferase. It is the catalytic component of a multiprotein complex that facilitates 2′-O-methylation of ribosomal RNAs (rRNAs), a ...
Yun Shi   +6 more
doaj   +1 more source

New Perspectives on Escherichia coli Signal Peptidase I Substrate Specificity: Investigating Why the TasA Cleavage Site Is Incompatible with LepB Cleavage

open access: yesMicrobiology Spectrum, 2023
Escherichia coli signal peptidase I (LepB) has been shown to inefficiently cleave secreted proteins with aromatic amino acids at the second position after the signal peptidase cleavage site (P2′).
Joanna E. Musik   +8 more
doaj   +1 more source

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4+ T-cell-dependent strain-transcending protective immunity in rodent models

open access: yesmBio, 2023
Malaria is a leading cause of illness and death in children under 5 years of age in Sub-Saharan Africa. Currently, there is no highly efficacious malaria vaccine capable of inducing long-lasting immunity.
Winter A. Okoth   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy